MX9703484A - Compuestos de lactona macrociclicos y su procedimiento de produccion. - Google Patents

Compuestos de lactona macrociclicos y su procedimiento de produccion.

Info

Publication number
MX9703484A
MX9703484A MX9703484A MX9703484A MX9703484A MX 9703484 A MX9703484 A MX 9703484A MX 9703484 A MX9703484 A MX 9703484A MX 9703484 A MX9703484 A MX 9703484A MX 9703484 A MX9703484 A MX 9703484A
Authority
MX
Mexico
Prior art keywords
macrocyclic lactone
compound
production process
lactone compounds
lactone compound
Prior art date
Application number
MX9703484A
Other languages
English (en)
Other versions
MXPA97003484A (es
Inventor
Hiroyuki Nishida
Yuji Yamauchi
Taisuke Inagaki
Yasuhiro Kojima
Nakao Kojima
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MXPA97003484A publication Critical patent/MXPA97003484A/es
Publication of MX9703484A publication Critical patent/MX9703484A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Esta invencion proporciona un procedimiento para producir un compuesto de lactona macrocíclico, que comprende cultiva Actinoplanes sp. FERM BP-3832, en presencia de L-prolina, L-hidroxiprolina o ácido L-nipecotico, y después aislar un compuesto de lactona macrocíclico del caldo de fermentacion. Los compuestos producidos por este procedimiento incluyen un compuesto de la siguiente formula: (Ver Formula). La presente invencion también se refiere a una composicion farmacéutica que comprende dicho compuesto, que es util como agente inmunosupresor, antimicotico, antitumoral o similar.
MX9703484A 1994-11-10 1995-10-13 Compuestos de lactona macrociclicos y su procedimiento de produccion. MX9703484A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP9401896 1994-11-10
PCPCT/JP1994/001896 1994-11-10
JPJP94/01896 1994-11-10
PCT/IB1995/000870 WO1996015131A1 (en) 1994-11-10 1995-10-13 Macrocyclic lactone compounds and their production process

Publications (2)

Publication Number Publication Date
MXPA97003484A MXPA97003484A (es) 1997-08-01
MX9703484A true MX9703484A (es) 1997-08-30

Family

ID=1341416

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9703484A MX9703484A (es) 1994-11-10 1995-10-13 Compuestos de lactona macrociclicos y su procedimiento de produccion.

Country Status (12)

Country Link
US (2) US6001998A (es)
EP (1) EP0854874B1 (es)
JP (1) JP3061863B2 (es)
AT (1) ATE239024T1 (es)
CA (1) CA2204739C (es)
DE (1) DE69530616T2 (es)
DK (1) DK0854874T3 (es)
ES (1) ES2194054T3 (es)
FI (1) FI971995A0 (es)
MX (1) MX9703484A (es)
PT (1) PT854874E (es)
WO (1) WO1996015131A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2204739C (en) * 1994-11-10 2000-04-04 Hiroyuki Nishida Macrocyclic lactone compounds and their production process
ATE411019T1 (de) * 2001-05-02 2008-10-15 Brni Neurosciences Inst Kohlensäureanhydrase-aktivatoren zur verbesserung der lern- und gedächtnisleistung
US6551591B1 (en) 2001-09-07 2003-04-22 Essential Therapeutics, Inc. Antibiotics from microbispora
US6825229B2 (en) 2002-03-07 2004-11-30 Blanchette Rockefeller Neurosciences Institute Methods for Alzheimer's Disease treatment and cognitive enhancement
US20080004332A1 (en) * 2002-03-07 2008-01-03 Alkon Daniel L Methods for alzheimer's disease treatment and cognitive enhancement
US20050065205A1 (en) * 2002-03-07 2005-03-24 Daniel Alkon Methods for Alzheimer's disease treatment and cognitive enhance
CN1946656B (zh) * 2004-02-17 2011-08-24 托马斯·E·约翰逊 形成大环化合物的方法、组合物和设备
TW201206425A (en) * 2004-05-18 2012-02-16 Brni Neurosciences Inst Treatment of depressive disorders
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
CA2598805A1 (en) * 2005-02-24 2006-08-31 Biocern, Inc. Sperm cell separation methods and compositions
WO2006119211A2 (en) * 2005-05-02 2006-11-09 Genaera Corporation Methods and compositions for treating ocular disorders
US20070054890A1 (en) * 2005-07-29 2007-03-08 Alkon Daniel L Protein synthesis required for long-term memory is induced by PKC activation on days preceding associative learning
CA2659242C (en) 2006-07-28 2015-08-11 Blanchette Rockefeller Neurosciences Institute Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory
CA2697960A1 (en) * 2006-08-30 2008-03-06 Biocern, Inc. Sperm cell separation methods and compositions containing aptamers or nucleic acid sequences for use therein
US7867988B2 (en) 2006-09-13 2011-01-11 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
US8088789B2 (en) 2006-09-13 2012-01-03 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
US10695327B2 (en) 2006-09-13 2020-06-30 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
EP2121001B1 (en) 2007-02-09 2014-12-17 Blanchette Rockefeller Neurosciences, Institute Therapeutic effects of bryostatins on ischemia/stroke-induced memory impairment and brain injury
KR20140049054A (ko) * 2007-02-09 2014-04-24 블랜체트 록펠러 뉴로사이언시즈 인스티튜트 두부 외상으로 유발된 기억 장애 및 뇌 손상에 대한 브리오스타틴, 브리오로그 및 기타 관련 물질의 치료학적 효과
US8410066B2 (en) * 2009-05-01 2013-04-02 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors
JP5833007B2 (ja) * 2009-08-31 2015-12-16 ドクター・レディーズ・ラボラトリーズ・リミテッド ステロイドを含む局所製剤
US9107890B2 (en) 2010-07-08 2015-08-18 Blanchette Rockefeller Neurosciences Institute PKC activators and anticoagulant in regimen for treating stroke
CA2808660A1 (en) 2010-08-19 2012-02-23 Blanchette Rockefeller Neurosciences Institute Treatment of cognitive disorders associated with abnormal dendritic spines using pkc activators
JP6422778B2 (ja) 2011-11-13 2018-11-14 ブランシェット・ロックフェラー・ニューロサイエンスィズ・インスティテュート Ｐｋｃアクチベーターおよびその組合せ
JP2018521113A (ja) 2015-05-11 2018-08-02 アルコン、ダニエル・エル． ＡｐｏＥ４対立遺伝子の存在を決定した後のＰＫＣ活性化因子を使用した神経変性状態の治療
CN107827803A (zh) * 2017-11-28 2018-03-23 绍兴厚普生物科技有限责任公司 一种从发酵液中提取l‑羟脯氨酸的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6903238A (es) * 1968-03-04 1969-09-08
US5091389A (en) * 1991-04-23 1992-02-25 Merck & Co., Inc. Lipophilic macrolide useful as an immunosuppressant
US5674732A (en) * 1992-04-27 1997-10-07 Pfizer Inc. Rapamycin producer
CA2106034A1 (en) * 1992-09-24 1994-03-25 Ralph J. Russo 21-norrapamycin
CA2204739C (en) * 1994-11-10 2000-04-04 Hiroyuki Nishida Macrocyclic lactone compounds and their production process

Also Published As

Publication number Publication date
EP0854874A1 (en) 1998-07-29
ATE239024T1 (de) 2003-05-15
PT854874E (pt) 2003-07-31
ES2194054T3 (es) 2003-11-16
DK0854874T3 (da) 2003-06-02
CA2204739C (en) 2000-04-04
FI971995L (fi) 1997-05-09
US6001998A (en) 1999-12-14
JP3061863B2 (ja) 2000-07-10
DE69530616D1 (de) 2003-06-05
FI971995A7 (fi) 1997-05-09
EP0854874B1 (en) 2003-05-02
US6187568B1 (en) 2001-02-13
JPH11507907A (ja) 1999-07-13
WO1996015131A1 (en) 1996-05-23
DE69530616T2 (de) 2004-04-01
FI971995A0 (fi) 1997-05-09

Similar Documents

Publication Publication Date Title
ES2194054T3 (es) Compuestos de lactona macrociclica y su procedimiento de produccion.
Scervino et al. Arbuscular mycorrhizal colonization of tomato by Gigaspora and Glomus species in the presence of root flavonoids
DE69018529D1 (de) Phospholipase A2-Inhibitor, Mikroorganismen, die diesen Inhibitor erzeugen und mehrere Verfahren zu seiner Herstellung.
ATE311405T1 (de) Hochreine lipopeptide, lipopeptid mizellen, deren herstellung und arzneimittel
AR001931A1 (es) Compuesto de 7-acilamino-3-iminometil (sustituido)cefalosporinas un proceso para su producción intermediarios en su producción una composición farmacéutica que contiene tales compuestos su utilizacióncomo compuestos farmacéuticos y un método para tratar enfermedades microbianas mediante administración de tales compuestos
ATE466866T1 (de) Synthetisches oligomannosid, seine herstellung und verwendung
AR034190A1 (es) Composicion, procesos y microorganismos para biocontrol de enfermedades de plantas
DE60232158D1 (de) Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
PT94555A (pt) Metodo para a producao de um derivado de equinocandina b, util como antibiotico
ZA202408256B (en) Crystalline form of 1,1,1,3,3,3-hexafluoropropan-2-yl (s)-1-(pyridazin-3-ylcarbamoyl)-6 azaspiro[2.5]octane-6-carboxylate as monoacylglycerol lipase inhibitor
ES2176262T3 (es) Acido 2-arilalquil-o arilalquenil-ciclopentano heptenoico, y derivados como agentes terapeuticos.
HRP20090382T1 (hr) Uređaj i postupak za proizvodnju biološko aktivnih spojeva fermentacijom
Naruse et al. Aspochalasin E, a new antibiotic isolated from a fungus
Jegorov et al. Destruxin Ed1 a cyclopeptide from the fungus Metarhizium anisopliae
Fontana et al. New polyketide peroxides from Okinawan marine sponge Plakortis sp.
DE3378058D1 (en) The novel microorganism strain chromobacterium violaceum, pharmaceutically active compounds being produced by the strain, a process for preparing the compounds and the use of these compounds as medicaments
DE69302267D1 (de) Actinoplanes als erzeuger von rapamycin
BG108151A (en) Caloporoside derivatives, methods for the production thereof and their use
TR199801288T2 (xx) Oksid�l birimlerinden yap�lm�� macrosiklik bile�enler
Itokawa et al. PREPARATION OF [Cys2]-RA-VII; THE FIRSTSULFUR CONTAINING ANALOGUE OF RAS POSSESSING ANTITUMOR ACT l V lm
DE68916659D1 (de) WS-9326 A, WS-9326B und deren Derivate.
MX9709494A (es) Compuestos peptidicos ciclicos, procedimiento para su produccion, composiciones que los contienen y uso de los mismos.
ES471709A1 (es) Un procedimiento microbiologico para la preparacion de un nuevo complejo antibiotico
Nasini et al. Isolation and structure elucidation of aza-sesquiterpenoids of protoilludane origin formed by shaken cultures of the fungus Clavicorona divaricata
BR0013547A (pt) Processo de preparação de quinoleìna-5,8-dionas

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees